-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Sabra Health Care REIT, Lowers Price Target to $21

Benzinga·07/08/2026 17:43:51
Listen to the news
UBS analyst Michael Goldsmith maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and lowers the price target from $22 to $21.